HEXO to begin trading on the NYSE American

HEXO Corp. (TSX:HEXO) is pleased to announce that its common shares have been approved for listing on the NYSE American LLC and will commence trading effective at the open of markets on January 23, 2019.

Australis Capital Invests $3 Million in CBD Extraction Company

Australis Capital Inc. (CSE: AUSA) is pleased to announce the Company has invested $3,000,000 USD in Folium Biosciences, the largest vertically integrated producer, manufacturer, and distributor of hemp derived phytocannabinoids in the United States.

Aurora to Acquire Whistler Medical Marijuana

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has entered into a letter of intent to acquire all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation, in an all-share transaction valued at up to approximately $175 million, including certain milestone payments.

Aphria Reports Revenue of $21.7 Million and Shakes Up Executive Team

Aphria Inc. (TSX: APHA andNYSE: APHA) today reported its results, for the second quarter ended November 30, 2018, and the decision by its Chief Executive Officer, Vic Neufeld, and Co-founder Cole Cacciavillani, to transition out of their executive roles over the coming months.